more

West Pharmaceutical Services (WST)

(Real Time Quote from BATS)

$316.01 USD

-2.01 (-0.63%)

Updated Jul 23, 2024 03:53 PM ET

After-Market: $316.27 +0.26 (0.08%) 4:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.15%
2	Buy	17.88%
3	Hold	9.47%
4	Sell	5.14%
5	Strong Sell	2.57%
S&P	500	11.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5 4

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth C Momentum C VGM

Industry Rank:

Bottom 36% (160 out of 250)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Retain Luminex (LMNX) Stock for Now

by Zacks Equity Research Published on July 13,2020

Luminex (LMNX) continues to benefit from robust product portfolio, solid molecular diagnostics and ARIES platforms.

medical

BD Collaborates With BARDA to Combat Coronavirus Crisis

by Zacks Equity Research Published on July 13,2020

Becton, Dickinson (BDX) forms a strategic public-private partnership with BARDA to help the U.S. government in its efforts to fight the COVID-19 pandemic and future pandemics.

medical

Baxter Gets FDA Nod for Altapore Shape Bioactive Bone Graft

by Zacks Equity Research Published on July 10,2020

Baxter (BAX) receives FDA approval for Altapore Shape that will provide surgeons versatile options to advance the art of healing and boost clinical outcomes during a surgery.

medical

Jobless Claims Hit 4-Month Low in Early July: An Analysis

by Zacks Equity Research Published on July 10,2020

Jobless claims drops with the relaxation of lockdowns and the gradual reopening of businesses. Early July numbers better expectations, signalling the restoration of a flagging coronavirus-stung economy.

3 Growth-Focused MedTech Stocks to Buy Amid Coronavirus Crisis

by Sriparna Ghosal Published on July 10,2020

Once the pandemic-led crisis is over, these MedTech growth-focused stocks will flourish on a number of positive developments.

medical

BD Receives EUA for New Antigen Test to Combat COVID-19

by Zacks Equity Research Published on July 08,2020

Becton, Dickinson (BDX) receives EUA from the FDA for a rapid, point-of-care, antigen test to detect SARS-CoV-2 in 15 minutes.

medical

Zacks.com featured highlights include: Teekay Tankers, Tesla, NextEra Energy, Nice and West Pharmaceutical Services

by Zacks Equity Research Published on July 06,2020

Zacks.com featured highlights include: Teekay Tankers, Tesla, NextEra Energy, Nice and West Pharmaceutical Services

Here's Why You Should Invest in OPKO Health (OPK) Stock Now

by Zacks Equity Research Published on July 06,2020

OPKO Health (OPK) continues to benefit from lucrative prospects in RAYALDEE and BioReference platforms.

Luminex Boosts Product Portfolio With New xMAP Technology

by Zacks Equity Research Published on July 06,2020

Luminex (LMNX) commences rollout of new xMAP INTELLIFLEX Systems, which will expand its xMAP Technology.

Jobs Market Strengthening Fast: 4 Sector ETFs & Stocks to Buy

by Sanghamitra Saha Published on July 03,2020

The U.S. economy unexpectedly added 4.8 million jobs in June, breezing past economists??? expectations of job gains of 2.9 million.

etfs

5 Low Leverage Stocks to Buy Amid Coronavirus-Led Debacle

by Zacks Equity Research Published on July 02,2020

Investors should know how much debt a company owns, because the higher the degree of financial leverage, higher is the interest payment for the capital borrowed.

Sustainable Investment Forms Part of the New Normal: 5 Picks

by Sreoshi Bera Published on July 02,2020

ESG policies and practices yielded positive outcomes during the coronavirus slump. Also, millennials-driven sustainable investing trend will continue post-pandemic.

Zacks.com featured highlights include: Kroger, AbbVie, W.W. Grainger, West Pharmaceutical Services and Taiwan Semiconductor Manufacturing Company

by Zacks Equity Research Published on July 01,2020

Zacks.com featured highlights include: Kroger, AbbVie, W.W. Grainger, West Pharmaceutical Services and Taiwan Semiconductor Manufacturing Company

by Zacks Equity Research Published on July 01,2020

Zacks.com featured highlights include: Kroger, AbbVie, W.W. Grainger, West Pharmaceutical Services and Taiwan Semiconductor Manufacturing Company

Masimo's New Solution to Reduce Opioid Withdrawal Symptoms

by Zacks Equity Research Published on July 01,2020

Masimo's (MASI) new solution can help reduce symptoms associated with opioid withdrawal, thereby helping OUD patients with their treatment.

medical

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

by Zacks Equity Research Published on June 30,2020

Allscripts (MDRX) continues to benefit from lucrative deals and strong prospects in Sunrise EHR. However, margin contraction remains a woe.

medical

Luminex Expands COVID-19 Testing With New Antibody Test

by Zacks Equity Research Published on June 30,2020

Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.

medical

5 Great Dividend Growth Stocks Amid Market Volatility

by Sweta Killa Published on June 30,2020

The second wave of coronavirus infections has flared up volatility and made investors scurry for safety and regular income. This has resulted in higher appeal for dividend investing.

Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

by Zacks Equity Research Published on June 29,2020

CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D. However, forex remains a woe.